These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24192449)

  • 21. Treatment and Prognosis of Rare Breast Cancers.
    Terando AM; Agnese DM; Holmes DR
    Ann Surg Oncol; 2015 Oct; 22(10):3225-9. PubMed ID: 26259751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The promise and challenges of rare cancer research.
    Komatsubara KM; Carvajal RD
    Lancet Oncol; 2016 Feb; 17(2):136-138. PubMed ID: 26868336
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.
    Mathoulin-Pélissier S; Pritchard-Jones K
    Eur J Surg Oncol; 2019 Jan; 45(1):22-30. PubMed ID: 29526369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recommendations for diagnosis and treatment of tuberous sclerosis].
    Dorofeeva MIu; Belousova ED; Pivovarova AM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(3):58-74. PubMed ID: 24781229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Centralized treatment of rare types of cancer].
    Schem BC
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2088. PubMed ID: 12555641
    [No Abstract]   [Full Text] [Related]  

  • 27. What a strange thing it is to live.
    García Jordá E
    Clin Transl Oncol; 2009 Mar; 11(3):123-5. PubMed ID: 19293048
    [No Abstract]   [Full Text] [Related]  

  • 28. Developing a strategy for the management of rare diseases.
    Taylor CM; Karet Frankl FE
    BMJ; 2012 Apr; 344():e2417. PubMed ID: 22498954
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rare tumors: the need for special centers].
    Massard C
    Bull Cancer; 2014 Feb; 101(2):115. PubMed ID: 25813683
    [No Abstract]   [Full Text] [Related]  

  • 30. Rethinking the nonprofit foundation: an emerging niche in the rare disease ecosystem.
    Bakker AC; La Rosa S
    EMBO Mol Med; 2017 Sep; 9(9):1179-1182. PubMed ID: 28743783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Austrian and European initiatives in the field of rare diseases perspectives for a "marginal group" of many millions of patients].
    Laimer M; Prodinger C; Ahlgrimm-Siess V; Hintner H; Bauer JW
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):261-4. PubMed ID: 25721645
    [No Abstract]   [Full Text] [Related]  

  • 32. Rarity and review: evidence-based practice for uncommon diseases.
    Bryson GL
    Can J Anaesth; 2013 May; 60(5):419-22. PubMed ID: 23526356
    [No Abstract]   [Full Text] [Related]  

  • 33. [Towards targeted answers to emergency issues for rare diseases].
    Duguet C
    Med Sci (Paris); 2018 May; 34 Hors série n°1():16-18. PubMed ID: 29911547
    [No Abstract]   [Full Text] [Related]  

  • 34. Treating rare disorders: time to act on unfair prices.
    The Lancet Neurology
    Lancet Neurol; 2017 Oct; 16(10):761. PubMed ID: 28920873
    [No Abstract]   [Full Text] [Related]  

  • 35. [Care networks in oncology, an evidence for all?].
    Ray-Coquard I; Ducimetière F; Farsi F
    Bull Cancer; 2013; 100(7-8):650-4. PubMed ID: 24063023
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of research collaborations and consortia in rare cancers.
    Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I
    Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ophthalmic oncology: how to search, appraise, and report evidence.
    Singh N; Singh AD
    Int Ophthalmol Clin; 2015; 55(1):1-7. PubMed ID: 25436489
    [No Abstract]   [Full Text] [Related]  

  • 38. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rare diseases: "a public health priorty". Interview by Catherine Holué].
    Podeur A
    Rev Prat; 2012 Jan; 62(1):79-80. PubMed ID: 22335073
    [No Abstract]   [Full Text] [Related]  

  • 40. Good-quality research in rare diseases: trials and tribulations.
    Bolignano D; Pisano A
    Pediatr Nephrol; 2016 Nov; 31(11):2017-23. PubMed ID: 26817476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.